Spark Biomedical Announces Investment by Northwell Holdings to Advance Their OhmBody™ Transcutaneous Auricular Neurostimulation (tAN) for Menstruation

Spark Biomedical Awarded an NIH Grant to Study the Treatment Effects of tAN® for Alcohol Withdrawal Symptoms

STTR Phase IAUD study to be conducted in partnership with Menninger Clinic and BaylorCollege of Medicine

Spark Biomedical Publishes First Peer-Reviewed Trial Showing Wearable Device Reduces Heavy Menstrual Bleeding

Pilot study demonstrates over 50% reduction in menstrual blood loss and improved symptoms using non-invasive, drug-free therapy